Influence of seizures on early development in tuberous sclerosis complex

Jamie K Capal1, Beatriz Bernardino-Cuesta2, Paul S Horn1

  • 1Department of Neurology MLC 2015, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.

Insights

Early seizures in Tuberous Sclerosis Complex (TSC) negatively impact infant development. Seizure onset age is the most critical factor for long-term developmental outcomes in children with TSC.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Genetics

Background:

  • Tuberous Sclerosis Complex (TSC) is frequently associated with epilepsy.
  • The impact of seizures on neurodevelopment in TSC is not fully understood, especially in early childhood.
  • Prospective, longitudinal data are needed to clarify this relationship.

Purpose of the Study:

  • To investigate the relationship between seizures and early developmental outcomes in infants with TSC.
  • To identify specific seizure characteristics that predict developmental trajectories.

Main Methods:

  • Analysis of 130 infants (0-36 months) with TSC from a multicenter, prospective observational study.
  • Longitudinal evaluations included cognitive, adaptive, and autism spectrum disorder (ASD)-specific measures.
  • Continuous seizure history collection (type, frequency, onset age).

Main Results:

  • Infants with seizures showed poorer developmental outcomes compared to those without seizures at all time points.
  • Infantile spasms were associated with worse outcomes at 12, 18, and 24 months.
  • Earlier seizure onset and higher seizure frequency correlated with more significant developmental delays, with onset age being the strongest predictor.

Conclusions:

  • Early seizure onset in TSC significantly impacts neurodevelopment from infancy through 24 months.
  • Age of seizure onset is a critical determinant of developmental outcomes in young children with TSC.
  • These findings underscore the importance of early seizure management in TSC for optimizing developmental trajectories.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K